Sciendox
Haicang · Founded 2005
About Sciendox
Sciendox is a platform for research and development that provides an instrument with the ability to automatically identify parasite forms, detect common viruses that cause diarrhea, such as rotavirus and adenovirus, and detect the gastric helicobacter pylori, which is the primary cause of gastric cancer, among other functions.
Company Facts
- Founded: 2005
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2018)
- Website: http://sciendox.com
- Phone: +86 0592-5752336
Industries & Categories
Biotechnology, Manufacturing, Medical Device
Canonical: https://fsome.com/organization/sciendox-100456 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.